Compumed Inc (CMPD) 0.0740 $CMPD
Axial and Peripheral Bone Densitometers - 2014 Global Strategic Business Report.
M2 - Fri Oct 24, 8:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s3fz9n/bone) has announced the addition of the "Bone Densitometers - Global Strategic Business Report." report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 18 companies including many key and niche players. This report analyzes the worldwide markets for Bone Densitometers in Units and US$ Thousands by the following Product Segments: - Axial Bone Densitometers - Peripheral Bone Densitometers Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competitive Factors 3. Reimbursements: Vital For Market Expansion 4. Product Overview 5. Osteoporosis: An Overview 6. Bone Densitometry Alternatives 7. Osteoporosis Drug Market - Impact On Diagnostics 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape - Total Companies Profiled: 18 (including Divisions/Subsidiaries - 19) - The United States (5) - Japan (1) - Europe (
- - France (2) - - Germany (1) - - The United Kingdom (1) - - Italy (1) - - Spain (1) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) Companies Mentioned - Beammed Ltd. - CompuMed, Inc. - GE Healthcare - Hologic, Inc. - Lone Oak Medical Technologies, LLC For more information visit http://www.researchandmarkets.com/research/s3fz9n/bone
HOLX: 26.89 (+0.10)
Diagnostic Electrocardiograph (ECG) Market 2014-2020 - Product, End-User & by Lead Type Analysis
M2 - Mon Sep 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6mqrkd/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020 The global diagnostic ECG market in the resting system segment had the largest share of the total diagnostic ECG market in 2013 and will continue to grow in the next five years to retain the leading position by 2020. The high growth in holter monitor segment is attributed to the low costs and space efficiency. Factors such as technological advancements in communication, low power circuit design for better and safer ECG devices, portable features with lower power consumption, more accuracy and capacity to incorporate the latest diagnostic features are driving the diagnostic ECG market. North America accounted for the largest market share in the diagnostic ECG market, whereas the APAC region is expected to register the highest growth rate due to its enormous growth opportunities and manufacturing cost benefits. The large patient base and increasing income levels are also expected to propel the growth of this market. The diagnostic ECG devices are increasingly being networked across various hospitals. Most of the larger hospitals are preferring computerization for maintaining electrocardiogram records and investing steadily in data management systems to allow physicians to access the comparative analysis of the patients' overall data. The advanced technologies such as the wireless technologies also provide growth opportunities. Moreover, the rising incidences of cardiac diseases and diseases such as diabetes and hypertension have also contributed to the growth of the diagnostic ECG market. The resting ECG devices segment had the largest share, while the holter monitor systems market was the fastest growing segment in 2013. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the resting ECG devices segment. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. GE Healthcare was the leader in the diagnostic ECG market in 2013. GE also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Philips Healthcare distantly followed GE in the diagnostic ECG market in 2013. The other major players in the market are Mindray Medical (China), Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.). Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User - Hospitals (Small, Medium, and Large) - Home /Ambulatory Care - Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/6mqrkd/diagnostic
Diagnostic Electrocardiograph (ECG) Market to 2020: Product (Resting, Stress, Holter Monitor) & Lead Type (Single, 3-6, 12) Analysis
M2 - Wed Jul 23, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nwbk54/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020. The market is driven by the rise in geriatric population, growing incidences of lifestyle diseases, and technological advancements. However, the decline of reimbursement policies will restrain the growth of this market to an extent. The holter monitor ECG devices will be the most fruitful segment for the companies to invest in the coming years. The resting ECG devices segment was the leading segment owing to the expanding geriatric population and growing incidences of cardiac diseases and other lifestyle diseases such as diabetes and hypertension. The holter diagnostic ECG device on the other hand was the fastest growing segment and is expected to grow at a healthy pace in the coming years, driven by the advancements in technology. While segmenting the market with respect to number of leads the 3-6 lead segment had the largest market share followed by the 12 lead segment. The 3-6 lead segment is also expected to grow at the fastest pace in the forecast period from 2013 to 2020. More number of leads captures more signals, thereby giving a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3-6 lead and 12-lead ECG device segments will grow at higher CAGRs than single-lead ECG devices. With respect to the end users, the global diagnostic ECG market is divided into hospitals, home/ambulatory care research centers, diagnostic centers, rehabilitation centers, clinics, physician offices, and surgical centers. The hospital segment will observe a high growth due to the new technologies launched and the purchasing of an entire new suit of diagnostic ECG devices. Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User Hospitals (Small, Medium, and Large) Home /Ambulatory Care Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles - Cardionet Inc. - Compumed Inc. - Ge Healthcare - Mindray Medical International Limited - Mortara Instrument, Inc. - Nihon Kohden Corporation - Royal Philips Healthcare - Schiller AG - Spacelabs Healthcare Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/nwbk54/diagnostic
MR: 26.87 (+0.30)
Global Bone Densitometers Market Report 2014
M2 - Tue Jul 22, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qpmg5/global_bone) has announced the addition of the "Global Bone Densitometers Market 2014-2018" report to their offering. Advances in bone densitometer technology coupled with an increase in access of these technologies in emerging markets such as China, Brazil, Japan, and India is serving as an opportunity for investors. New product introductions have been observed across a wide range of bone measurement technologies. The most accurate and widely accepted technique is axial/central DEXA. Lunar iDXA for bone health by GE Healthcare and DXA Technology by Hologic are some of the products launched in this market, which enhanced the growth opportunities in emerging economies. According to the report, the Global Bone Densitometers market is driven by several factors, of which the increase in the aging population is one of the major drivers. As a person ages, the incidence of bone-related disorders such as osteoporosis also increases, resulting in the demand for bone densitometers. Further, the report states that one of the main challenges is the high cost of bone densitometers. Despite the numerous benefits, the high cost of treatment options hinders the acceptability among patients. Also, as a result of this, patients are reluctant to opt for such devices and prefer medications. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The Global Bone Densitometry market can be divided into two segments: - Axial Bone Densitometer - Peripheral Bone Densitometer. Key Vendors - CooperSurgical Inc. - Diagnostic Medical Systems S.A - GE Healthcare Ltd - Hologic Inc. Other Prominent Vendors - BeamMed Ltd - CompuMed Inc. - Lone Oak Medical Technologies LLC - Osteometer MediTech Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/2q...lobal_bone
HOLX: 26.89 (+0.10)
Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts
PR Newswire Europe - Mon Jul 21, 9:28AM CDT
LOS ANGELES, July 21, 2014 /PRNewswire/ --
Axial and Peripheral Bone Densitometers - 2014 Global Strategic Business Report.
M2 - Fri Oct 24, 8:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s3fz9n/bone) has announced the addition of the "Bone Densitometers - Global Strategic Business Report." report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 18 companies including many key and niche players. This report analyzes the worldwide markets for Bone Densitometers in Units and US$ Thousands by the following Product Segments: - Axial Bone Densitometers - Peripheral Bone Densitometers Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competitive Factors 3. Reimbursements: Vital For Market Expansion 4. Product Overview 5. Osteoporosis: An Overview 6. Bone Densitometry Alternatives 7. Osteoporosis Drug Market - Impact On Diagnostics 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape - Total Companies Profiled: 18 (including Divisions/Subsidiaries - 19) - The United States (5) - Japan (1) - Europe (
- - France (2) - - Germany (1) - - The United Kingdom (1) - - Italy (1) - - Spain (1) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) Companies Mentioned - Beammed Ltd. - CompuMed, Inc. - GE Healthcare - Hologic, Inc. - Lone Oak Medical Technologies, LLC For more information visit http://www.researchandmarkets.com/research/s3fz9n/bone HOLX: 26.89 (+0.10)
Diagnostic Electrocardiograph (ECG) Market 2014-2020 - Product, End-User & by Lead Type Analysis
M2 - Mon Sep 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6mqrkd/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020 The global diagnostic ECG market in the resting system segment had the largest share of the total diagnostic ECG market in 2013 and will continue to grow in the next five years to retain the leading position by 2020. The high growth in holter monitor segment is attributed to the low costs and space efficiency. Factors such as technological advancements in communication, low power circuit design for better and safer ECG devices, portable features with lower power consumption, more accuracy and capacity to incorporate the latest diagnostic features are driving the diagnostic ECG market. North America accounted for the largest market share in the diagnostic ECG market, whereas the APAC region is expected to register the highest growth rate due to its enormous growth opportunities and manufacturing cost benefits. The large patient base and increasing income levels are also expected to propel the growth of this market. The diagnostic ECG devices are increasingly being networked across various hospitals. Most of the larger hospitals are preferring computerization for maintaining electrocardiogram records and investing steadily in data management systems to allow physicians to access the comparative analysis of the patients' overall data. The advanced technologies such as the wireless technologies also provide growth opportunities. Moreover, the rising incidences of cardiac diseases and diseases such as diabetes and hypertension have also contributed to the growth of the diagnostic ECG market. The resting ECG devices segment had the largest share, while the holter monitor systems market was the fastest growing segment in 2013. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the resting ECG devices segment. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. GE Healthcare was the leader in the diagnostic ECG market in 2013. GE also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Philips Healthcare distantly followed GE in the diagnostic ECG market in 2013. The other major players in the market are Mindray Medical (China), Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.). Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User - Hospitals (Small, Medium, and Large) - Home /Ambulatory Care - Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/6mqrkd/diagnostic
Diagnostic Electrocardiograph (ECG) Market to 2020: Product (Resting, Stress, Holter Monitor) & Lead Type (Single, 3-6, 12) Analysis
M2 - Wed Jul 23, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nwbk54/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020. The market is driven by the rise in geriatric population, growing incidences of lifestyle diseases, and technological advancements. However, the decline of reimbursement policies will restrain the growth of this market to an extent. The holter monitor ECG devices will be the most fruitful segment for the companies to invest in the coming years. The resting ECG devices segment was the leading segment owing to the expanding geriatric population and growing incidences of cardiac diseases and other lifestyle diseases such as diabetes and hypertension. The holter diagnostic ECG device on the other hand was the fastest growing segment and is expected to grow at a healthy pace in the coming years, driven by the advancements in technology. While segmenting the market with respect to number of leads the 3-6 lead segment had the largest market share followed by the 12 lead segment. The 3-6 lead segment is also expected to grow at the fastest pace in the forecast period from 2013 to 2020. More number of leads captures more signals, thereby giving a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3-6 lead and 12-lead ECG device segments will grow at higher CAGRs than single-lead ECG devices. With respect to the end users, the global diagnostic ECG market is divided into hospitals, home/ambulatory care research centers, diagnostic centers, rehabilitation centers, clinics, physician offices, and surgical centers. The hospital segment will observe a high growth due to the new technologies launched and the purchasing of an entire new suit of diagnostic ECG devices. Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User Hospitals (Small, Medium, and Large) Home /Ambulatory Care Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles - Cardionet Inc. - Compumed Inc. - Ge Healthcare - Mindray Medical International Limited - Mortara Instrument, Inc. - Nihon Kohden Corporation - Royal Philips Healthcare - Schiller AG - Spacelabs Healthcare Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/nwbk54/diagnostic
MR: 26.87 (+0.30)
Global Bone Densitometers Market Report 2014
M2 - Tue Jul 22, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qpmg5/global_bone) has announced the addition of the "Global Bone Densitometers Market 2014-2018" report to their offering. Advances in bone densitometer technology coupled with an increase in access of these technologies in emerging markets such as China, Brazil, Japan, and India is serving as an opportunity for investors. New product introductions have been observed across a wide range of bone measurement technologies. The most accurate and widely accepted technique is axial/central DEXA. Lunar iDXA for bone health by GE Healthcare and DXA Technology by Hologic are some of the products launched in this market, which enhanced the growth opportunities in emerging economies. According to the report, the Global Bone Densitometers market is driven by several factors, of which the increase in the aging population is one of the major drivers. As a person ages, the incidence of bone-related disorders such as osteoporosis also increases, resulting in the demand for bone densitometers. Further, the report states that one of the main challenges is the high cost of bone densitometers. Despite the numerous benefits, the high cost of treatment options hinders the acceptability among patients. Also, as a result of this, patients are reluctant to opt for such devices and prefer medications. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The Global Bone Densitometry market can be divided into two segments: - Axial Bone Densitometer - Peripheral Bone Densitometer. Key Vendors - CooperSurgical Inc. - Diagnostic Medical Systems S.A - GE Healthcare Ltd - Hologic Inc. Other Prominent Vendors - BeamMed Ltd - CompuMed Inc. - Lone Oak Medical Technologies LLC - Osteometer MediTech Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/2q...lobal_bone
HOLX: 26.89 (+0.10)
Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts
PR Newswire Europe - Mon Jul 21, 9:28AM CDT
LOS ANGELES, July 21, 2014 /PRNewswire/ --
